Anheuser-Busch InBev SA/NV

AB InBev — Business Economics

Ticker: BUD | Currency: USD (NYSE ADR; also ABI on Euronext Brussels in EUR)

AB InBev is the world's largest brewer — a scale-driven premiumization machine that has shifted from volume growth to revenue-per-hectoliter growth as its primary economic engine. The company operates in ~50 countries with 500+ brands spanning value to super-premium (Budweiser, Corona, Stella Artois, Michelob Ultra, plus hundreds of local champions). It earns ~$59B in annual revenue with normalized EBITDA margins around 33–34%.

How it makes money: Volume × revenue per hectoliter, minus aggressive cost discipline inherited from 3G Capital's ownership culture. Global beer volumes have been roughly flat to slightly declining for years. AB InBev's growth formula is almost entirely premiumization and pricing — trading consumers up from value to premium brands at higher margin. In FY2024, total volumes declined ~1.4% but revenue per hl grew ~5%, delivering organic revenue growth of ~2.6%. This pattern — flat/negative volume offset by positive price/mix — has been the story for a decade.

Trajectory: Mixed. Mexico and parts of Latin America remain strong growth vectors; the US market suffered lasting share loss from the 2023 Bud Light controversy (volumes still below pre-incident levels); China/Asia Pacific faces macro headwinds; Africa offers a long-term secular growth runway but is early-stage. The business is not declining, but it is mature in its core developed markets.

Win-win? Partially. AB InBev has a well-documented reputation for extracting value from suppliers and distributors through scale leverage and exclusive agreements. The 3G-influenced cost culture is efficient but has drawn criticism for squeezing stakeholders. This is not a cooperative ecosystem builder — it is a dominant scale operator.

Key governing metrics: (1) Revenue per hectoliter (the single most important indicator), (2) total volumes in hectoliters, (3) normalized EBITDA margin, (4) net debt/EBITDA (still ~3.0–3.2x; deleveraging from the $100B+ SABMiller deal remains a decade-long overhang), (5) organic revenue growth by region.

Deterioration signals: US share loss is real but stabilizing. No product obsolescence risk — beer is a permanent category. The bigger structural question is whether premiumization can keep offsetting flat volumes indefinitely, and whether the massive debt load constrains capital allocation flexibility.

Market Overview — Anheuser-Busch InBev

The global beer market is a ~$650B revenue pool growing at a low-single-digit rate driven almost entirely by price/mix, not volume — a neutral backdrop that rewards scale operators like AB InBev but offers no organic volume tailwind.

Global beer volumes have been flat-to-slightly-declining for a decade in developed markets (US, Western Europe), while emerging markets (Africa, Southeast Asia, parts of Latin America) still provide modest volume growth from demographics and rising incomes. The real growth engine is premiumization: consumers trading up to craft, imports, and above-premium brands. Health/wellness trends and spirits-based RTDs are structural headwinds eating into beer's share of total alcohol occasions.

The industry is among the most consolidated in consumer staples. AB InBev holds ~27% of global beer volume, Heineken ~12%, and the next three (Carlsberg, China Resources Snow, Molson Coors) hold 5-6% each. Below the top five, thousands of local brewers fragment the remainder. This consolidation gives the leaders unmatched distribution leverage and procurement scale, but limits further M&A upside — the easy roll-ups are done.

The value chain (raw materials → brewing → distribution → retail) favors incumbents: distribution is capital-intensive, highly local, and the single greatest barrier to entry. AB InBev's ownership of direct distribution in many markets is a durable structural advantage.

Net assessment: A mature, consolidated market with no volume tailwind but a reliable revenue growth floor from premiumization. Adequate for a scale incumbent — not exciting for a growth investor.

AB InBev possesses a genuine but geographically uneven moat. Its competitive advantages are real in most of the world; the question is whether the US erosion represents a one-market setback or a signal about brand fragility more broadly.

Scale dominance is the core moat. With ~28% global beer volume (Heineken at ~11%), AB InBev spreads procurement, brewing, and marketing costs across a base no competitor can match. This shows up directly in industry-leading EBITDA margins (~34%). Zero-based budgeting compounds this advantage operationally.

Distribution infrastructure in Latin America and Africa functions as a near-chokepoint. In Brazil (~60% share) and several African markets, AB InBev controls cold-chain logistics that would take decades and billions to replicate. This is arguably the most durable moat source.

Brand pricing power is mixed. Corona and Stella Artois carry genuine premiumization power globally. But the Bud Light episode proved that mass-market beer brands carry cultural risk — US share fell ~4 points and has not recovered, with volume migrating permanently to Modelo (ironically, brewed by Constellation using AB InBev's former Mexican assets).

Regulatory barriers and high capital requirements provide a secondary moat layer — alcohol licensing, advertising restrictions, and the sheer capital needed for global brewing infrastructure deter new entrants at scale, though not craft or spirits competitors.

The moat is wide in aggregate but narrowing at the margin — the structural shift toward spirits, RTDs, and premiumization benefits AB InBev's top-end portfolio while eroding the mass-lager foundation that generates most of its volume. The US share loss is a permanent impairment to one market, not a systemic failure — but it demonstrates that brand moats in commoditized categories are thinner than they appear.

AB InBev's financial profile is defined by a single tension: world-class cash generation sitting beneath a mountain of acquisition-driven debt and goodwill. The operating machine is excellent; the balance sheet legacy of SABMiller is not.

Returns on capital are optically mediocre, operationally outstanding. Reported ROIC runs 8–10% against a total capital base bloated by ~$65–70 billion of goodwill. Strip out acquisition intangibles, and the return on tangible operating assets is exceptional — EBITDA margins of ~34–35% are best-in-class among global brewers. This is the classic "great operations buried under acquisition accounting" pattern. Returns comfortably exceed WACC, but barely — meaning shareholder value creation since the SABMiller deal has been incremental, not transformational.

Debt is heavy but manageable and well-structured. Net debt has been ground down from ~$105 billion (2016) to roughly $55–58 billion by FY2025, with net debt/EBITDA approaching ~3.0x from a peak of ~4.5x. The debt is long-dated (weighted-average maturity ~15 years), nearly all fixed-rate, and investment-grade rated (BBB+/Baa1). Annual interest expense of ~$4–5 billion is comfortably covered by ~$20 billion of normalized EBITDA and ~$10–12 billion of free cash flow. This business could service its debt through a severe downturn — beer demand is recession-resilient and the maturity profile eliminates near-term refinancing risk.

Cash earnings quality is high, with one caveat. FCF conversion is strong: operating cash flow of ~$14–16 billion less ~$4–5 billion capex yields ~$10–12 billion in free cash flow, well in excess of ~$5 billion in reported net income. The caveat is AB InBev's heavy reliance on "normalized" metrics that strip out restructuring, mark-to-market hedging losses, and impairment charges. These exclusions are individually defensible but cumulatively material — investors should anchor on IFRS reported figures, not management's adjusted numbers.

The goodwill overhang is the real balance-sheet risk. At ~$65–70 billion, AB InBev carries more goodwill than almost any company on earth. If secular beer volume declines accelerate or key markets (Africa, China) structurally disappoint, impairment charges could be enormous — non-cash but destructive to book equity and potentially triggering debt covenant scrutiny. No major impairment has been taken yet, but the risk is permanent and asymmetric.

Most recent financial data: FY2025 20-F (filed with SEC, fiscal year ended 31 December 2025).

Runway for Reinvestment

AB InBev's reinvestment runway is short. The company already dominates global beer — there is no next SABMiller to acquire, and volume growth in mature markets is structurally zero. Organic revenue growth of ~5-7% (FY2023-2025) has been almost entirely price/mix, which requires minimal incremental capital but also has natural limits as consumers trade down or away.

Excluding ~$65B of acquisition goodwill, underlying ROIC on tangible assets is strong (high teens). On total capital, returns compress to ~5-7% — barely above WACC. This is the permanent legacy of the SABMiller deal's price tag.

Management has deployed FCF rationally for a business with limited reinvestment options:

The near-absence of growth capex or bolt-on M&A confirms management sees few high-return reinvestment opportunities. AB InBev is a cash-return vehicle, not a compounder. That is honest capital allocation, but it caps long-term value creation.

AB InBev remains the world's largest brewer by a wide margin, but its competitive position has weakened meaningfully in its most profitable market. The Bud Light controversy in mid-2023 triggered a permanent ~5-point US share loss (from ~40% to ~35%), and by 2025 the lost volumes had not returned. The primary beneficiary was Constellation Brands, whose Modelo Especial became the #1 US beer brand, along with Molson Coors (Coors Light, Miller Lite). AB InBev's structural advantage — unmatched EBITDA margins driven by scale — remains intact globally, but the US share erosion is a genuine competitive wound, not a temporary dislocation.

Outside the US, the picture is stronger: dominant in Brazil (~60% share), leading in key African markets via the SAB legacy, and holding the premium position in China through Budweiser APAC. Heineken is the closest global peer and a more diversified growth story, though at materially lower margins.

AB InBev's margin superiority is undeniable, but it trades at a premium to peers like Heineken and Molson Coors that have better volume momentum. Constellation commands even higher beer-segment margins thanks to the Modelo franchise's pricing power and growth. The competitive question is whether AB InBev's global scale and premiumization strategy can offset a structurally smaller US footprint — the answer is probably yes for EBITDA stability, but it limits rerating potential.

Management & Shareholder Orientation

AB InBev is a controlled company, and minority shareholders should understand exactly what that means. The Belgian brewing families (EPS — de Spoelberch, de Mévius, Van Damme) and the 3G Capital founders (Lemann, Telles, Sicupira) govern through Stichting AB InBev, which holds effective control despite economic ownership below 50%. This structure gives the controlling consortium board appointment rights and strategic veto power. ABI invokes NYSE's controlled-company exemption, meaning the board need not have a majority of independent directors.

Skin in the game is exceptionally high. The controlling families have multi-generational, concentrated wealth in ABI — tens of billions of dollars. CEO Michel Doukeris (appointed 2021) holds meaningful equity through long-term incentive plans tied to EBITDA growth and TSR. This is not a management team skimming fees; their fortunes rise and fall with the stock.

Capital allocation improved markedly after the 2018 dividend cut (halved to accelerate deleveraging post-SABMiller). Net debt/EBITDA has since dropped from ~4.5× to roughly 3.0-3.5× by FY2025, and the company reintroduced buybacks (~$1B annually). Dividends have been ratcheted back up, though remain below pre-cut levels in real terms.

The concern is governance, not incentives. Related-party transactions exist (Ambev minority, licensing arrangements) though disclosed at market terms. The dual-class-like control means minority shareholders cannot meaningfully challenge strategic direction — the 2016 SABMiller acquisition (which created the debt burden) was a controlling-shareholder decision. Altria and the Santo Domingo family (BevCo) have been steadily selling their legacy positions, which adds supply overhang but also simplifies the register.

No material securities-enforcement actions against the company or leadership. Some antitrust investigations in India and other markets are routine for a dominant brewer and not indicative of management malfeasance.

Management Competence & Ethics

AB InBev's management is operationally competent but has a mixed capital allocation record defined by one enormous bet. The ~$100B SABMiller acquisition (2016) delivered its promised $3.2B in cost synergies, but it also loaded the balance sheet with ~$100B in net debt and required a ~$15.5B Africa goodwill impairment in 2018 plus a 50% dividend cut to stabilize the balance sheet. Net debt/EBITDA has since improved from ~6x to roughly 3.5x by FY2025, aided by the $11B Carlton & United divestiture to Asahi and disciplined free cash flow. The recent $2B share buyback program signals leverage comfort, but nine years of deleveraging was a steep price for the deal.

CEO Michel Doukeris (since mid-2021) has corrected the prior Brito-era underinvestment in brands — marketing spend is up and digital platforms (BEES, Zé Delivery) are well-executed. However, management badly mishandled the 2023 Bud Light controversy: the slow, indecisive response turned a one-week social media event into a permanent ~25% US volume loss for the brand, ceding the #1 US beer position to Modelo Especial. This was a significant unforced error in execution and crisis management.

On transparency, the FY2025 20-F confirms no financial restatements, no auditor changes (PwC), and no error corrections. The company discloses material litigation — mainly Brazilian tax disputes (CARF) and various antitrust proceedings — none individually existential. The complex shareholder structure (AB InBev Stichting, 3G Capital interests, and Belgian families controlling ~50%+ of votes) limits minority shareholder influence, a governance concern worth noting.

Anheuser-Busch InBev — Valuation

AB InBev is fairly valued — neither obviously cheap nor expensive. At $154B market cap, the stock offers a 7.3% FCF yield and trades at 10.2x EV/EBITDA, reasonable for a mature consumer staple generating $11B+ in annual free cash flow. The embedded growth expectation is modest (~5% EPS growth), which is achievable but not exciting. There is no meaningful margin of safety given $59B in net debt and negative tangible book value.

What the current price embeds. The trailing P/E of 17.0x (on TTM EPS of ~$4.61) and forward P/E of 15.8x imply consensus expects mid-single-digit earnings growth — roughly 7-8% EPS CAGR. This is plausible through a combination of 2-3% organic revenue growth (premiumization), modest margin expansion, declining interest expense as debt rolls, and ~$2B+ annual buybacks. The question is whether volume headwinds in the US and China offset these levers.

Management guidance and credibility. AB InBev has consistently guided for 4-8% organic EBITDA growth and deleveraging below 2x net debt/EBITDA. On margins, they have delivered — EBITDA margin expanded from 32.8% (2022) to 35.1% (2025). On deleveraging, progress has been painfully slow: net debt/EBITDA sits at 2.84x, still well above target. On volumes, they have persistently disappointed, particularly in North America post-2023. Guidance credibility: strong on cost discipline, weak on top-line ambitions.

Liquidation value. Tangible book is −$73B. The balance sheet carries ~$130B in goodwill/intangibles from the SABMiller acquisition. In a breakup, individual brand portfolios (Budweiser, Corona, Stella Artois, local champions) have real franchise value, but $73B in debt means equity holders would recover pennies. This is purely a going-concern investment.

Intrinsic value — FCF-based. FY2025 FCF was $11.2B; TTM OCF is $17.4B. Using normalized FCF of ~$11.5B, growing at 3-4% (in line with organic EBITDA growth), discounted at 8.5% WACC, the equity value is approximately $155-170B — roughly in line with the current market cap.

The base case assumes 3% EBITDA CAGR (management's lower-bound guidance), stable multiples, and moderate deleveraging. The bull case requires premiumization to accelerate and the US business to stabilize. The bear case reflects persistent volume declines, FX headwinds in emerging markets, and multiple compression if deleveraging stalls. The expected value of ~$175B implies roughly 13% upside over five years before dividends — a total return of roughly 5-6% annualized including the ~2% dividend yield. That is a bond-like return, not an equity-like one.

Long-term Valuation

AB InBev is a ~7-9% annual compounder — a modest wealth preserver, not a wealth creator. At 17x trailing earnings with mid-single-digit EPS growth plus a ~2% dividend, the math yields roughly 1.5–2x over a decade. Not bad, but unremarkable.

The reinvestment flywheel is weak. Revenue has been flat at ~$59B for four years. Growth comes almost entirely from premiumization (trading consumers up to Corona, Stella, Michelob Ultra) and cost discipline — not from expanding the pie. Incremental returns on capital are declining: the $100B+ goodwill from SABMiller generates 11% ROE and ~5% ROA. Each marginal dollar invested widens the moat less than the last.

The moat itself — brands, distribution scale, procurement power — is durable but not deepening. Beer's share of alcohol is structurally declining in developed markets. The accelerating buyback ($2.3B in 2025) is the strongest compounding lever remaining: at current prices, 1.5% annual share reduction adds meaningfully to per-share value.

Thesis-breaking signal: US volume declines accelerating beyond -3% annually for two consecutive years, indicating brand impairment rather than a temporary boycott hangover. Also watch net debt/EBITDA — if it stops declining from 2.8x, capital allocation flexibility disappears.

This business will be relevant in 20 years; it just won't be dramatically larger.

Risk Assessment — Anheuser-Busch InBev SA/NV

AB InBev's risk profile is dominated by one factor: a still-heavy balance sheet operating across volatile emerging-market currencies. The business itself is durable — beer is a millennia-old category with no plausible path to obsolescence — but the capital structure amplifies what would otherwise be manageable operating risks.

Debt is the permanent-impairment vector. Net debt stood at ~$62B at FY2025 (~3.2× EBITDA), down materially from the ~$95B post-SABMiller peak but still enormous in absolute terms. The note maturities listed in the 20-F stretch to 2060 with coupons of 4–6%. A simultaneous EM currency collapse (BRL, ZAR, COP account for ~35% of EBITDA) and volume downturn could squeeze coverage ratios. Probability of distress: low (~5–10%) given strong cash generation (~$7B free cash flow), but non-zero and path-dependent on macro.

US share loss is real but bounded. The Bud Light brand erosion since 2023 cost ~4 points of US beer share. This is painful, not existential — the US is ~25% of EBITDA and Michelob Ultra, Busch, and the broader portfolio partially backfill. The risk is that it signals a broader vulnerability: AB InBev's dominant brands can lose relevance faster than premiumization can compensate.

Secular volume decline in developed markets (~1–2% annual declines) is uncertainty, not risk — it is already priced in and offset by pricing power and mix-shift toward premium/super-premium.

Governance: Controlling shareholder families (via Stichting) hold ~50% of votes. 3G Capital's zero-based-budgeting DNA has historically underinvested in brands and innovation. This is a slow-burn risk if premiumization requires sustained marketing spend.

Currency and geopolitical exposure is structural and unhedgeable over a 10-year horizon — it creates noise, not permanent impairment.

Single greatest risk: A severe EM crisis (hyperinflation in Brazil or similar) coinciding with developed-market volume weakness, while $60B+ of debt is outstanding. Probability: ~8%. Impact: material equity impairment but likely not total loss given asset value.

Final Verdict: AB InBev — Adequate, Not Compelling

AB InBev is a good business generating mediocre returns for shareholders. That tension defines the investment case.

The underlying asset is strong: $59B in revenue, $20.8B EBITDA at 31.5% margins, $11.2B in FCF — all powered by unrivaled global scale and distribution infrastructure that no competitor can replicate. The beer business itself is durable. People will drink beer in 2036.

But durable and investable are different questions. Revenue has flatlined at ~$59B for four consecutive years (2022–2025). Volume is stagnant globally; all growth comes from price/mix and premiumization — a strategy with diminishing returns as consumers trade down in tighter economies. The US franchise, once the crown jewel, suffered permanent share loss post-Bud Light crisis, with Modelo (owned by Constellation) now the #1 beer brand in America. That's not coming back.

The balance sheet remains the central constraint. Net debt of $59B — nearly 3x EBITDA — absorbs a huge share of FCF into interest ($3.9B) and principal reduction. Tangible book value is negative $73B, a reminder of the SABMiller acquisition's true cost. The controlling shareholder structure means minority investors have no say in capital allocation.

The math doesn't work for a BUY. Expected market cap of ~$180B versus $154B today implies ~3% annualized price appreciation. Add ~2.5% from dividends and buybacks, and total return lands at 5–6% — a levered bond dressed as equity. For that return, you're bearing real risks: $59B in debt, a damaged US brand portfolio, and structural category headwinds from spirits and RTDs.

Strongest counterargument: Emerging-market premiumization (Africa, Latin America) could accelerate EBITDA growth beyond 3%, and accelerated buybacks at 10x EBITDA could compound EPS faster than my base case. This is possible but not probable enough to change the verdict.

For existing holders: Hold. Cash generation protects against permanent impairment, and the 7% FCF yield provides a reasonable floor. But don't add — capital earns more elsewhere.

What would change my view: Net debt below $45B (2.0x EBITDA), sustained US share stabilization, or a price below $60 creating genuine margin of safety.

Gaps to research further:

• BEES (B2B digital platform) monetization trajectory and whether it creates a genuine data moat
• Africa volume trends post-2025 — is premiumization actually working or is it just price?
• FX hedging book details; half of EBITDA is earned in EM currencies